MoneyWorks4Me

A minor change in the total revenue was seen in the June 2022 quarter. The total revenue for the quarter stood at Rs. 1094.95 millions against Rs. 1047.78 millions during year ago period.Net Profit of the company move down -31.97% to Rs. 30.05  millions from Rs. 44.17 millions  in the same quarter last year.Operating profit for the quarter ended June 2022 decreased to 103.84 millions as compared to 108.72 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1094.95 1047.78 4.50 1094.95 1047.78 4.50 4510.68 3846.98 17.25
Other Income 0.07 5.22 -98.66 0.07 5.22 -98.66 0.89 0.00 0.00
PBIDT 103.84 108.72 -4.49 103.84 108.72 -4.49 491.45 580.20 -15.30
Interest 35.45 29.62 19.68 35.45 29.62 19.68 111.62 93.26 19.69
PBDT 68.39 79.10 -13.54 68.39 79.10 -13.54 379.83 486.94 -22.00
Depreciation 26.00 23.90 8.79 26.00 23.90 8.79 102.49 91.75 11.71
PBT 42.39 55.20 -23.21 42.39 55.20 -23.21 277.34 395.19 -29.82
TAX 12.34 11.03 11.88 12.34 11.03 11.88 80.76 115.48 -30.07
Deferred Tax -0.96 -4.22 -77.25 -0.96 -4.22 -77.25 -7.32 22.80 -132.11
PAT 30.05 44.17 -31.97 30.05 44.17 -31.97 196.58 279.71 -29.72
Equity 158.28 158.28 0.00 158.28 158.28 0.00 158.28 158.28 0.00
PBIDTM(%) 9.48 10.38 -8.60 9.48 10.38 -8.60 10.90 15.08 -27.76
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..